Effect of TTR stabilisers on strain values derived by echocardiography in patients with wild type ATTR Amyloidosis

Back

HFA Premium Access

Effect of TTR stabilisers on strain values derived by echocardiography in patients with wild type ATTR Amyloidosis

Session: ePosters in myocardial disease - hypertrophic cardiomyopathy (2)

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor J. Westphal (Jena, DE)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Julian Georg Westphal

University Hospital of Jena, Jena (Germany)

0 follower

7 more presentations in this session

Recognizing red flags: don't judge a book by its cover. data from a multicentric nationwide study

Speaker: Doctor A. Pinho (Porto, PT)

Mavacamten use in a real-world cohort of obstructive hypertrophic cardiomyopathy patients: insights from the initial centre experience

Speaker: Doctor M. Lima (Lisbon, PT)

Estimating hypertrophic cardiomyopathy genotype pre-test probability: an online calculator

Speaker: Mr P. Kopp (Stony Brook, US)

Differentiating clinical trial endpoints in transthyretin cardiac amyloidosis is significantly improved with continuing medical education

Speaker: Doctor C. Rohani-Montez (London, GB)

Changes in global myocardial work indices during mavacamten treatment in obstructive hypertrophic cardiomyopathy

Speaker: Professor R. Sepp (Szeged, HU)

Access the full session

ePosters in myocardial disease - hypertrophic cardiomyopathy (2)

Speakers: Doctor J. Westphal, Doctor A. Pinho, Doctor M. Lima, Mr P. Kopp, Doctor C. Rohani-Montez...

Access

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources